BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Paradigms Foundation
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240301T080000
DTEND;TZID=Europe/Paris:20240302T170000
DTSTAMP:20240829T153453Z
CREATED:20240829T153453Z
LAST-MODIFIED:20240829T153453Z
UID:9787-1709280000-1709398800@paradigms.foundation
SUMMARY:INIC 2024
DESCRIPTION:Held from March 1-2\, 2024\, in Riyadh\, Saudi Arabia\, INIC 2024 is the first-ever scientific conference in the region focused on neuroimmunology. Esteemed local and international speakers will deliver cutting-edge presentations aimed at educating both professionals and non-professionals on critical topics such as Multiple Sclerosis (MS) and neuroimmunological diseases. Through these sessions\, the conference is seeking to improve early diagnosis\, enhance interventions\, and empower patients with knowledge and advocacy. \n\n\n\nParadigMS experts are playing a significant role\, presenting on advancements in MS treatments and the integration of AI in personalized medicine. Notable topics include novel therapies targeting microglial cells\, updates on stem cell transplantation for MS\, and the evolving understanding of MS as a continuum of chronic inflammation and disease progression. \n\n\n\nThis groundbreaking conference provides a unique platform for advancing the understanding and management of neuroimmunological diseases\, ultimately aiming to improve patient outcomes across the region. \n\n\n\nThe presentations will be recorded and shared on our platform.
URL:https://paradigms.foundation/event/inic-2024/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2024/08/INIC-24.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20231207T190000
DTEND;TZID=Europe/Paris:20231207T200000
DTSTAMP:20240725T120240Z
CREATED:20231103T152902Z
LAST-MODIFIED:20240725T120240Z
UID:7803-1701975600-1701979200@paradigms.foundation
SUMMARY:ParadigMS Pre-MENACTRIMS Symposium 2023
DESCRIPTION:Join us at ParadigMS Pre-MENACTRIMS Symposium!  \n\n\n\nThursday\, 7th of December 2023\, Abu Dhabi\, UAE \n\n\n\nThis unique learning experience focused on advancing excellence in Multiple Sclerosis education and research promises to be a gathering of minds and insights\, with leading experts in the field\, engaging discussions\, and networking opportunities. \n\n\n\nFind out more by exploring the event website and register to secure your spot and be part of this extraordinary live learning experience! \n\n\n\nWith thanks to our sponsor\, who supports this event without any involvement in the elaboration of the presentations. \n\n\n\n\n\n\n\nMerck Global Medical Education & Academic Organization Relations \n\n\n\nAccess the Merck knowledge forum at http://academe-ms.com/ \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nProgrammeTab SPeakersSponsors\n\n\n\n\n\ntext on speakers \n\n\n\n\n\nThis is content on the sponsors
URL:https://paradigms.foundation/event/paradigms-pre-menactrims-symposium-2023/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2023/11/MSC2023-ParadigMS-Newsletter-2.jpg
ORGANIZER;CN="ParadigMS":MAILTO:secretariat@paradigms.foundation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230909T090000
DTEND;TZID=Europe/Paris:20230909T150000
DTSTAMP:20240404T125804Z
CREATED:20240404T112701Z
LAST-MODIFIED:20240404T125804Z
UID:8799-1694250000-1694271600@paradigms.foundation
SUMMARY:Expert Meeting 9th of September 2023
DESCRIPTION:On Saturday 9th September\, ParadigMS brings together MS experts to discuss and peer review educational materials on multiple sclerosis treatment and care. A detailed agenda will be shared closer to the meeting but how to uncover subtle/silent progressions is one of the hot topics that will be discussed. \n\n\n\n\n\nWith thanks to our sponsor\, who supports this event without any involvement in the elaboration of the presentations.
URL:https://paradigms.foundation/event/expert-meeting-9th-of-september-2023/
ATTACH;FMTTYPE=image/webp:https://paradigms.foundation/wp-content/uploads/2024/04/expert-sep-2-3b57c37f-1.webp
ORGANIZER;CN="ParadigMS":MAILTO:secretariat@paradigms.foundation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230420T173000
DTEND;TZID=UTC:20230420T223000
DTSTAMP:20240522T142508Z
CREATED:20221207T123417Z
LAST-MODIFIED:20240522T142508Z
UID:5122-1682011800-1682029800@paradigms.foundation
SUMMARY:ParadigMS 8th Belgian Symposium 2023
DESCRIPTION:Register now for the eighth ParadigMS Belgian Symposium!\n\n\n\nParadigMS Foundation invites Belgian neurologists\, MS nurses and other interested professionals to mark Thursday 20th April 2023 in their agenda!The workshops\, plenary session\, sponsored break-outs and panel discussions bring you new insights that improve your day-to-day clinical practice. \n\n\n\nWhy participate? \n\n\n\n• As a neurologist or nurse: Get inspired by MS experts and share your own experiences\, meet colleagues and discover the work of other neurologists in the field of MS.• As a resident: Get familiar with this specific field of neurology and build a networking within Belgian MS care.• As an non-health care practitioner: Hear the view of MS experts and connect to the Belgian MS treatment and care community. \n\n\n\nThe top 5 objectives to make your participation a success? \n\n\n\n1. Ask your question or share a comment related to MS treatment and care2. Meet colleagues that work on similar clinical cases3. Get informed on some of the latest news related to MS treatment and care4. Establish new contacts that can support your daily clinical work or research project5. Learn from the international experience from our speakers \n\n\n\n\n\nJoin the live stream\n\n\n\nAs from Monday 17th April\, you find here the links to access the live stream of the ParadigMS Symposium. It allows you to test your connection.  \n\n\n\n\nAccess the live stream of the plenary session via this link.\n\n\n\nAccess the live stream of the Roche sponsored break-out session via this link (Rethinking Treatment Strategies in MS by Dr. Tatjana Reynders).\n\n\n\nAccess the live stream of the Janssen sponsored break-out session via this link (Paradigm shift in first line MS treatment by Dr. Bart Van Wijmeersch).\n\n\n\n\nIMPORTANT: You are directed to a form to leave your details. Once you submit\, you are directed to the page with the live stream. Each time you close the browser window of the live stream\, you can re-enter via the same procedure (leaving your details etc).  \n\n\n\nWe collect your information via this form to be able to accurately evaluate the participation to our Symposium. \n\n\n\nTranslation: You can select your language in the live stream window. If you join onsite\, you can also access the translation via the live stream.  \n\n\n\nQ&A and comments during the plenary session: Submit them via Slido.com with event code: #1434258 or directly in the Slido window available at the right of the live stream window.  \n\n\n\nFees\, translation and accreditation \n\n\n\nThe Symposium is offered for free\, thanks to our sponsors whom were not involved in the elaboration of the scientific programme and presentations.  \n\n\n\nAll plenary sessions are simultaneously translated from English to Dutch and French.  \n\n\n\nRIZIV/INAMI accreditation will be requested for the Workshops (1 hour) and the keynotes and panel discussion (1 hour) – this accreditation applies to Belgian physicians only. \n\n\n\n\n\n\n\nProgrammeWorkshop & Keynote abstractSpeakersSponsorsFAQPracticalSponsored break-outs\n\n\n\nProgrammeParadigMS Belgium Symposium 2021 – Thursday 24th JuneHybrid  \n\n\nTimeProgramme14:00– 17:00Pre-symposium online 1-1 meetings session (online)17:00 – 17:30Pre- symposium on-site 1-1 meetings session ( Van Der Valk) 17:00 – 17:30Welcome coffee Worshop 1 ( at Van Der Valk) 17:30 – 19:00Workshop 1: Risk Manegment in the  Treatment of MS (at Van Der Valk )  Workshop 2: Individualized Prognosis in MS- clinical cases ( online) 18:30 – 19:30Sign-in for the lectures and walking dinner ( at Van Der Vlak ) 19:00 – 19:30Sponsored break-out 1- New approaches to personalised medicine in MS: novel endpoints by BMS ( Van Der Valk and online)Sponsored break out 2- Smouldering part of the disease DMTs- what remains to achieve by Sanofi (online)19:30 – 19:45Welcome and Introduction ( on-site and online) 19:45 – 20:10Keynote and Q&A: Innate Immunity and the Role of Microglia in MS (on-site and online) 20:10 – 20:35Q&A and Panel Discussion on topics of the workshops and the keynote (on-site and online) 21:05 – 21:30Networking with coffee and dessert ( Van Der Valk) 21:05 – 22:15Post-symposium 1-1 meeting session (online)Post-symposium 1-1 meeting session ( Van Der Vlak) \n\n\n\n\n\n\nSpeakerWorkshop AbstractMelinda MagyariReal-life data on switching medicationWhile the increasing number of highly effective immunotherapies for multiple sclerosis has improved disease control\, no disease modifying therapy (DMT) is entirely effective in halting disease activity. Switching DMT should therefore be considered in cases of breakthrough disease or an inadequate response to therapy\, intolerability or specific side effects\, adverse events\, family planning\, compliance issues\, psychosocial reasons\, and economic reasons.The aging MS population also raises the need for de-escalation of DMT\, emphasizing the importance of the risks and benefits of such a switch which should be considered on a case-by-case basis. Real-life data can contribute with evidence on predictors of treatment response\, guide the selection of the most appropriate DMT for individual patients\, and inform treatment decisions when switching DMTs.Vincent Van PeschImmunology and the mechanisms of immune system dysfunctionImmunology is rapidly changing\, increasingly complex and interdisciplinary discipline and has entered the field of neurology for several diseases such as Multiple Sclerosis (MS)\, neuromyelitis optica\, myasthenia gravis or other less common disorders. This workshop will cover basic immunology concepts\, including the different types of immune cells and their function\, as well as the mechanisms of immune system activation and regulation. It will also provide the basis for understanding the role of immune cells and cytokines in the development of MS and the mechanisms of tissue damage\, as well as the mode of action of disease-modifying therapies. Participants will have the opportunity to engage in interactive discussions and case-based learning activities\, allowing for a more in-depth understanding of the functioning of the immune system and its relevance for MS and the treatment of immune-mediated neurological disorders.\n\n\nSpeakerKeynote AbstractNiels HellingsEpstein Barr Virus and Multiple Sclerosis: Old Wine in New Bottles?Epstein Barr Virus (EBV) and its possible involvement in the etiology of multiple sclerosis (MS) has regained a lot of attention lately. But did we really learn something new or do recent reports merely confirm what has been known for many years? Did we get any further than the paradigms which have been textbook knowledge for some time?In my talk\, I will summarize the most important facts on EBV and MS and emphasize the elements that are still unknown and should be subject of future research to get any idea about the pathogenicity of this herpes virus in MS. I will touch upon the limitations of reported studies and conclude by discussing possible therapeutic approaches that target EBV and may be considered once causality can be definitely proven one day. Letizia LeocaniNew technologies in the neurological field (OCT\, evoked potentials\, remote monitoring\, AI): What can I use today? And what is coming?Today\, evoked potentials and OCT are routinely used to detect subclinical involvement of eloquent pathways\, to confirm relapses or to monitor demyelination\, remyelination and axonal loss in trials targeting remyelination and neuroprotection. On the other hand\, extensive research\, also on a large scale\, is being conducted to validate and promote the use of digital technologies for remote monitoring\, with the final aim to ease disease management and to allow to empower self-monitoring by people with MS. All these measures\, to be integrated in the large portfolio already available including biomarkers and neuroimaging\, will require computing power and novel processing techniques\, from statistical approaches to artificial intelligence.\n\n\n\n\n\n\nSpeakerBiographyMelinda Magyari is the director of The Danish Multiple Sclerosis Registry (link: www.dmsr.dk/) and a consultant neurologist at the Danish Multiple Sclerosis Center (COI). Her major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in the changing epidemiology and gender differences. Using nationwide population-based data sources her research addresses questions on comorbidities\, reproductive issues\, risk factors and socioeconomic consequences in multiple sclerosis. She is involved in pharmacoepidemiological studies investigating the effectiveness and long-term safety of disease modifying therapies.Niels Hellings is Director of the Biomedical research Institute (BIOMED) and Professor Immunology at the Faculty of Medicine and Life Sciences of Hasselt University (COI).He graduated as master in bioscience-engineering at the Catholic University of Leuven (1996) and consequently obtained a PhD in immunology at Hasselt University (2000). He was visiting postdoctoral scientist at McGill University (Montréal)\, before returning to Hasselt University to set up his own research group. Currently\, Niels Hellings is director of the biomedical research institute (BIOMED) and professor in immunology at the faculty of Medicine and Life Sciences at Hasselt University. He heads the neuroimmune connections & repair (NIC&R) lab that includes 2 tenure track professors\, 3 post docs\, 15 predocs and 2 technicians and published 110 peer reviewed articles (H factor: 35; >3800 cites). The NIC&R lab focuses on immune mediated central nervous system damage and repair. To study this\, a wide variety of immunological and glial cell assays are applied including functional human in vitro assays and high dimensional flow cytometry. Apart from human in vitro studies\, experimental animal models of neuroinflammation and -repair are up and running. In addition to basic research\, collaborative valorization projects are set up with Flemish and international Biotech and Pharma. Niels Hellings is board member of the Belgian Immunological Society and Flanders Vaccine vzw.Letizia Leocani is Associate professor of Neurology at Vita-Salute San Raffaele University\, Neurologist in the Neurorehabilitation Unit of the Neurological Dep.t and supervisor of the Experimental neurophysiology Unit and of Magnetic IntraCerebral Stimulation (MagICSI) center – Institute of Experimental Neurology\, IRCCS Ospedale San Raffaele (COI). After her medical degree\, she obtained a PhD in Human Physiology and Neurology specialty and she has been Research Fellow at the Human Motor Control Section of the National Institutes of Health in Bethesda-USA. She is Co-Chair of the Clinical Neurophysiology scientific panel of the European Academy of Neurology. Her fields of interest involve translational validation of electrophysiological (advanced EEG analysis\, evoked and cognitive potentials) and structural (optical coherence tomography – OCT) markers of diseases of the central nervous system and of treatment strategies using non invasive brain stimulation to potentiate the effects of drugs and neurorehabilitation.Van Pesch served as neurology resident at the Department of Neurology\, Saint-Luc Hospital and then progressed in positions from Adjunct Clinical Head to Associate Clinical Head and finally to Adjunct Chief of Neurology Department at the Cliniques Universitaires Saint-Luc (COI). He is also responsible for the coordination and supervision of the neurophysiology unit and is consultant for the clinical biology department concerning neuro-immunological analysis. He obtained his medical degree in 1999 from the UCLouvain and then completed his PhD thesis in neuroimmunology in 2003. At the UCLouvain\, Dr Van Pesch is a Professor of Neurology and is responsible for teaching neuroimmunology and cerebrospinal fluid/neurochemistry analysis. He is the Principal investigator of the Neurochemistry Unit at the Institute of Neuroscience currently supervising 2 PhD students. Dr Van Pesch also greatly contributes to scientific publications and has over 169 published papers in a number of renowned journals. He is also co-editor of Frontiers Neurology\, section of Multiple Sclerosis and neuroimmunology and section of Neuroepidemiology and has Co-editor of the Acta Neurologica Belgica between 2014 and 2022.\n\n\nChair  BiographyBart Van Wijmeersch is a neurologist specialized in Multiple Sclerosis. He is medical director of the Rehabilitation and MS Center in Pelt where he leads the multidisciplinary MS-team. Furthermore\, he is an associate professor of Neurology at the University of Hasselt\, affiliated with the Biomedical Institute\, where he’s involved in pre-clinical as well as the clinical research on MS at the biomedical institute (BIOMED). He has a supporting role in all the immunological research on blood- and CSF samples of persons with MS and in EAE-animal models\, as well as in the rehabilitation research at REVAL. Immunological\, Biomarker\, MRI\, Electrophysiological and Rehabilitation research in MS come together in this way. He has an educational role in the faculty of medicine and physiotherapy.He’s a member of the Belgian Study Group of Multiple Sclerosis\, first President of ParadigMS and a member of advisory boards of different pharmaceutical companies with interest in Multiple Sclerosis.As acknowledgment of his scientific work\, he received an honorary award of the Flemish government in the summer of 2019.\n\n\nModeratorBiographyAs a media professional\, Lies Martens analyzes the errors companies make when they communicate with the press in a crisis. She is an expert\, coach and trainer in crisis communication\, media and presentation skills. Through many years of experience as a journalist\, she is also able to lead a debate and to ask the right questions as an interviewer.\n\n\n\n\n\n\n\n\nPlatinum sponsor \n\n\n\n\n\n\n\n\n\n\n\nPlatinum sponsor \n\n\n\n\n\n\n\n\n\n\n\nGold sponsor \n\n\n\n\n\n\n\n\n\n\n\nGold sponsor \n\n\n\n\n\n\nGold sponsor \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCan I change my registration?\n\n\n\n\nYes\, you can change the selections you made in your registration. Eg.: adding or deleting a specific session.You cannot however\, change an online into an on-site ticket or visa-versa. For this\, you will need to cancel your ticket and register for a new ticket.  \n\n\n\n\n\n\n\n\nI missed a session\, can I watch it somewhere?\n\n\n\n\nAll plenary sessions are recorded and can be watched at this platform.You need to create an account to access all ParadigMS learning materials. \n\n\n\n\n\n\n\n\nWhat happens to my personal data?\n\n\n\n\nParadigMS does not sell or transfers your personal details to any third party except for the following:1) Your first and last name are shared with our sponsors and partners. It allows them to know whom has registered and to invite those health care practitioners not yet registered. We do not share contact details (fe: email address). Should you not wish we share your first and last name with our sponsors and partners\, please let us know at secretariat@paradigms.foundation. 2) ParadigMS uploads your details into its contact database. ParadigMS uses this database to send information on its activities. You can always unsubscribe form that mailinglist.The general data protection policy of the organiser\, can be downloaded here.  \n\n\n\n\n\n\n\n\nCan I cancel my registration?\n\n\n\n\nYes\, you can cancel your registration. Certainly for onsite participants we very much appreciate if you let us know you cannot join – as it allows us to adjust the order for the catering in time.  \n\n\n\n\n\n\n\n\nWhat browser do we use to participate at the event?\n\n\n\n\nThe website is best used via Chrome or Firefox.  \n\n\n\n\n\n\n\n\nTerms and Conditions \n\n\n\n\nThe general terms and conditions of the organiser can be downloaded here. \n\n\n\n\n\n\n\n\nUntil when\, can I register this event?\n\n\n\n\nYou can register onsite until 15th April and online until 20th April. \n\n\n \n\n\n\n\n\n\n\n\nWhen: Thursday 20th April 2023 \n\n\nWhere? \n\n\nOnsite: Brussels Airport (Sheraton Hotel – Brussels Airport\, 1930 Brussel) \n\n\nOnline: Via paradigms.foundation (information to connect will be shared 5 working days beforehand) \n\n\nRegistration fee: free\, but pre-registration is mandatoryInterpretation: Live – From English to Dutch/ FrenchAccreditation: RIZIV/INAMI will be requested for the Workshops (1 hour) and the keynotes and panel discussion (1 hour) \n\n\nHow to get there? \n\n\nBy train: train station Brussels Airport is at walking distance and you avoid the traffic! \n\n\nBy car: carpark 1 at Brussels Airport is closest (and most expensive)\, carpark 2 and 3 are cheaper options and also at walking distance.  \n\n\n\n\n\n\nThe sponsored break-outs are also live streamed\, pre-registration is mandatory. \n\n\nFor both break-out sessions are only open for prescribing physicians. \n\n\nSponsorTopicParadigm shift in first line MS treatment by Dr. Bart Van Wijmeersch*Please note this beak-out session is only open for prescribing physiciansRethinking Treatment Strategies in MS by Dr. Tatjana Reynders*Please note this beak-out session is only open for prescribing physicians\n\n\nSpeakerBiographyBart Van Wijmeersch is a neurologist specialized in Multiple Sclerosis. He is medical director of the Rehabilitation and MS Center in Pelt where he leads the multidisciplinary MS-team. Furthermore\, he is an associate professor of Neurology at the University of Hasselt\, affiliated with the Biomedical Institute\, where he’s involved in pre-clinical as well as the clinical research on MS at the biomedical institute (BIOMED). He has a supporting role in all the immunological research on blood- and CSF samples of persons with MS and in EAE-animal models\, as well as in the rehabilitation research at REVAL. Immunological\, Biomarker\, MRI\, Electrophysiological and Rehabilitation research in MS come together in this way. He has an educational role in the faculty of medicine and physiotherapy.He’s a member of the Belgian Study Group of Multiple Sclerosis\, first President of ParadigMS and a member of advisory boards of different pharmaceutical companies with interest in Multiple Sclerosis.As acknowledgment of his scientific work\, he received an honorary award of the Flemish government in the summer of 2019.Tatjana Reynders studied medicine at UHasselt (Bachelor) and UGent (Master)\, after which she trained as a neurologist at the Free University of Brussels (VUB). Since 2018\, she has been working full time at the UZA as a neurologist with expertise in multiple sclerosis (MS) and neuroinflammatory diseases. In addition\, within neurophysiology\, she has developed strongly in evoked potentials and intraoperative neuromonitoring. In 2020\, she received a PhD in medical sciences from the VUB entitled: “The role of the gut microbiome and the autonomic nervous system in multiple sclerosis.” Her scientific interests lie in clinical and translational aspects of mechanisms of genesis and treatment of neuroinflammatory diseases\, including multiple sclerosis (MS)\, neurosarcoidosis and cerebral vasculitis.
URL:https://paradigms.foundation/event/8th-paradigms-belgian-symposium-thursday-20th-april-2023-brussels-airport/
LOCATION:Sheraton Hotel – Brussels Airport\, Brussels Airport\, Brussel\, 1930\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2022/12/LAU-PROD-banner-general-8th-Symposium-e1673870240166.jpg
ORGANIZER;CN="ParadigMS":MAILTO:secretariat@paradigms.foundation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230318T090000
DTEND;TZID=Europe/Paris:20230318T113000
DTSTAMP:20240923T085835Z
CREATED:20240404T114654Z
LAST-MODIFIED:20240923T085835Z
UID:8809-1679130000-1679139000@paradigms.foundation
SUMMARY:Expert Meeting 18th of March 2023
DESCRIPTION:ParadigMS board members meet virtually in March. At the Expert Meetings\, experts peer review each others educational slide decks with the objective to publish educational materials for clinical neurologists and nurses on behalf of ParadigMS. \n\n\n\nHere is the agenda of the meeting: \n\n\n\nSlide decks \n\n\n\n\nFINAL REVIEW: Paediatric MS – Lead: Melinda Magyari\n\n\n\nNEW: Cerebrospinal fluid (CSF) in the diagnosis of MS – Lead: Florian Deisenhammer\n\n\n\nNEW: Cognition in MS – Lead: Carlo Pozzilli and Bart Van Wijmeersch\n\n\n\n\nE-learning \n\n\n\n\nMicroglia and MS: Status\n\n\n\nNEW: max 1-hour asynchronous e-learning on how to uncover subtle\, silent progression in MS: Lead expert (max 2) to be assigned.
URL:https://paradigms.foundation/event/expert-meeting-18th-of-march-2023/
ATTACH;FMTTYPE=image/png:https://paradigms.foundation/wp-content/uploads/2024/04/WP-posts-ParadigMS-18.png
ORGANIZER;CN="ParadigMS":MAILTO:secretariat@paradigms.foundation
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221110
DTEND;VALUE=DATE:20221111
DTSTAMP:20230314T114940Z
CREATED:20221208T081604Z
LAST-MODIFIED:20230314T114940Z
UID:5152-1668038400-1668124799@paradigms.foundation
SUMMARY:ParadigMS-Pre-MENACTRIMS Symposium 2022
DESCRIPTION:As a warm-up for the Seventh MENACTRIMS Congress\, ParadigMS Foundation is organising an enriching Pre-MENACTRIMS Symposium on Thursday November 10\, 2022.\nThe Seventh Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) Congress will take place November 11 & 12\, 2022 at the Al Hambra\, Intercontinental City Stars\, Cairo\, Egypt\n\nPre-MENACTRIMS Symposium\n\nDate & Time:Thursday\, November 10\, 2021 at 18:30 (EET)\nLocation: Al Hambra\, Intercontinental City Stars\, Cairo\, Egypt\nAgenda:\n\n\n\n\n\n\n18:30 – 19:00\nRegistration and Welcome Coffee\n\n\n19:00 – 19:05\nWelcome by the chairs: Bassem Yamout and Celia Oreja-Guevara\n\n\n19:05 – 19:20\nLaura Airas\, Microglia\, The Basics\n\n\n19:20 – 19:35\nCelia Oreja-Guevara\, Microglia\, How to Target\n\n\n19:35 – 19:50\nCarlo Pozzilli\, Cognition in MS\, A Marker of Silent Progression?\n\n\n19:50 – 20:00\nLive Q&A and Panel Discussion\n\n\n\n\n\n\n\nWatch the on-demand webinars\n\nMore information about the MENACTRIMS Congress\n\nThe congress aim is to provide a forum of excellence in MS education and research. Building on the collective efforts of the scientific committee\, the meeting will deliver state-of-the-art presentations on MS by renowned international and regional keynote speakers. The content of the meeting includes up to date information on the latest treatments\, clinical research\, therapeutic strategies\, pathology\, imaging\, epidemiology\, diagnosis\, biomarkers\, neuromyelitis optica\, and much more.\n\nAdditional information can be found here.\n\n\n\nWith the support of :\nMerck\, Global Medical Education & Academic Organization Relations\nAccess the Merck knowledge forum at academe-ms.com
URL:https://paradigms.foundation/event/paradigms-pre-menactrims-symposium-2022/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2022/10/AdobeStock_289858374-bnw-1-scaled.jpeg
ORGANIZER;CN="ParadigMS":MAILTO:secretariat@paradigms.foundation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20221020T183000
DTEND;TZID=Europe/Paris:20221020T220000
DTSTAMP:20240404T125925Z
CREATED:20240404T122239Z
LAST-MODIFIED:20240404T125925Z
UID:8828-1666290600-1666303200@paradigms.foundation
SUMMARY:ParadigMS Master Class – 20th October 2022
DESCRIPTION:The Master Class aims to bring together health care practitioners participating both on site as well as online\, by offering a learning experience that can positively impact your clinical practice. Question and answer sessions and polls will be used to encourage participants to get involved and engage with the speakers and other participants. \n\n\n\n\n\n\n\nDATE & LOCATION \n\n\n\nThursday 20th October 2022Hybrid event – on site (Health Avenue\, Ikaroslaan 57\, 1930 Zaventem) and online. \n\n\n\nSTORY-LINE \n\n\n\nMS prognostication in practice: today and future perspectives \n\n\n\nMS prognostication provides the neurologist with a comprehensive overview of each patient’s current and potential future disease status. It can be used to identify ‘red flags’ in the patient’s profile indicating the need for heightened vigilance and/or a more aggressive treatment approach. \n\n\n\nIn this one-hour masterclass\, MS neurologists present three related subjects. First\, a prognostication tool is presented that can be used by neurologists in clinical practice. Next\, cases are presented where high efficacy pharmacological treatment is used depending on demographic factors\, clinical manifestations\, MRI observations and biomarkers. We conclude the session with a view on the potential of virtual care and digital biomarkers to complement the available patient data for a neurologist. \n\n\n\nPROGRAMME \n\n\n\n\n\n\n\nSPEAKERS \n\n\n\n\n\n\n\nWHO’S INVITED \n\n\n\nNeurologists • Neurologists in training • Nurses • Researchers • Rehabilitation professionals • Medical professionals
URL:https://paradigms.foundation/event/paradigms-master-class-20th-october-2022/
ATTACH;FMTTYPE=image/webp:https://paradigms.foundation/wp-content/uploads/2024/04/Master-Class-_-black-and-white-600-×-400-px-723dfce7.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220917T090000
DTEND;TZID=Europe/Paris:20220917T140000
DTSTAMP:20240404T130011Z
CREATED:20240404T115249Z
LAST-MODIFIED:20240404T130011Z
UID:8813-1663405200-1663423200@paradigms.foundation
SUMMARY:Expert Meeting 17th of September 2022
DESCRIPTION:This report provides a summary of scientific proceedings from the ParadigMS Expert Meeting. \n\n\n\nThe following ‘hot topics’ were on the agenda: \n\n\n\n\nPaediatric MS – Lead: Melinda Magyari\n\n\n\nCerebrospinal fluid (CSF) in the diagnosis of MS – Lead: Florian Deisenhammer\n\n\n\nCognition in MS – Lead: Carlo Pozzilli and Bart Van Wijmeersch\n\n\n\nTele-medicine and the use of digital tools in MS – Lead: Mona AlKhawajah\n\n\n\nOCT and microglia – Lead: Celia Oreja-Guevara
URL:https://paradigms.foundation/event/expert-meeting-17th-of-september-2022/
ATTACH;FMTTYPE=image/webp:https://paradigms.foundation/wp-content/uploads/2024/04/Capture-3-d936e18b.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220908T180000
DTEND;TZID=Europe/Paris:20220908T213000
DTSTAMP:20240522T142638Z
CREATED:20240404T120421Z
LAST-MODIFIED:20240522T142638Z
UID:8818-1662660000-1662672600@paradigms.foundation
SUMMARY:ParadigMS 8th Egypt Symposium on 8th and 9th of September 2022
DESCRIPTION:Save the Date! ParadigMS organises\, in collaboration with the Egyptian MS Society\, a two-day symposium that takes place from Thursday 8th September 2022 through Friday 9th September 2022 in Cairo\, Egypt. \n\n\n\nThe symposium brings ParadigMS’ peer reviewed presentations and workshops to Egypt and is an opportunity for both the presenters and participants to discuss on MRI\, latest available treatments\, immunosenescence\, prognosis in MS\, high efficacy treatments and family planning in a North-African context. The Symposium is sponsored by Novartis Egypt. \n\n\n\nWith thanks to our sponsor\, who supports this event without any involvement in the elaboration of the presentations.
URL:https://paradigms.foundation/event/8th-paradigms-egypt-symposium-on-8th-and-9th-of-september-2022/
ATTACH;FMTTYPE=image/webp:https://paradigms.foundation/wp-content/uploads/2024/04/Wordpress-presentation-7-a9d935c4.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220630T173000
DTEND;TZID=Europe/Paris:20220630T223000
DTSTAMP:20240522T142555Z
CREATED:20240404T123326Z
LAST-MODIFIED:20240522T142555Z
UID:8835-1656610200-1656628200@paradigms.foundation
SUMMARY:ParadigMS 7th Belgian Symposium – 30th June 2022
DESCRIPTION:We have chosen to offer a hybrid event\, featuring national and international speakers. (RIZIV/INAMI-accredited). \n\n\n\nAs in previous years\, the workshops and plenary session will provide you with knowledge that you can put to immediate use in your day-to-day practice. \n\n\n\nDATE & LOCATIONThursday 30th June 2022\, from 5.30 pmHybrid symposium – you can follow the symposium digitally or be there in person at the Van Der Valk Brussels Airport hotel in Machelen. \n\n\n\nTOPICS \n\n\n\n\nOnsite workshops on MRI & OCT and MS & Cognition\n\n\n\nOnsite and online keynotes and a panel discussion on precision medicine in MS and the concept of an MS care unit.\n\n\n\n\nWHO’S INVITED \n\n\n\nNeurologists • Neurologists in training • Nurses • Researchers • Rehabilitation professionals • Medical professionals  \n\n\n\nTOPICS \n\n\n\n\nOnsite workshops
URL:https://paradigms.foundation/event/7th-paradigms-belgian-symposium-30th-june-2022/
ATTACH;FMTTYPE=image/webp:https://paradigms.foundation/wp-content/uploads/2024/04/iStock-1224215350-1200x800-2-e1642518653906-d66a3420.webp
END:VEVENT
END:VCALENDAR